Aggregate Biosciences is a stealth-stage biotechnology company developing next-generation tools to tackle some of the most complex diseases in human health
Aggregate Biosciences is a stealth-stage biotechnology company developing next-generation tools to tackle some of the most complex diseases in human health. Backed by federal innovation grants and rooted in research from Rockefeller, Baylor, and Karolinska, we are building precision technologies designed for scale. We are early, well-connected, and focused on unlocking major opportunities at the intersection of structural biology and therapeutic design.